GovWire

Decision: CAP Bridging Mechanism products

Medicines Healthcare Products Regulatory Agency

April 17
11:42 2024

The CAP Bridging list comprises:

A GB licenced product (PLGB) to Northern Ireland for a period of 6 months or until the EC authorises a CAP in Northern Ireland or the EC refuses an application for the product, whichever is sooner.

For further information, please read our CAP Bridging Mechanism Guidance.

Published 6 September 2023
Last updated 17 April 2024 +show all updates
  1. Moved 'Casgevy 4-13 x 10^6 cells/mL dispersion for infusion' to Expired CAP Bridging list

  2. Active CAP Bridging List updated with new entry: Casgevy

  3. First published.

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: